This European approach to insulin management is now being introduced in Australia
Since the publication of the Diabetes Control and Complications Trial (DCCT) in 1993,1 improved glycaemic control in type 1 diabetes has been acknowledged as a desirable goal in theory, but frustratingly difficult to achieve in practice. Although bodies such as the American Diabetes Association recommend a glycated haemoglobin (HbA1c) target of < 7%,2 only around 20% of adults with type 1 diabetes under specialist supervision in Australian centres achieve this goal (data from the Australian National Diabetes Information Audit and Benchmarking Survey; Associate Professor Jeff Flack, Director, Diabetes Centre, Bankstown–Lidcombe Hospital, NSW, personal communication).
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group: N Engl J Med 1993; 329: 977-986.
- 2. American Diabetes Association. Standards of medical care in diabetes — 2006. Diabetes Care 2006; 29 Suppl 1: S4-S42.
- 3. DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ 2002; 325: 746.
- 4. Muhlhauser I, Berger M. Patient education — evaluation of a complex intervention. Diabetologia 2002; 45: 1723-1733.
- 5. Muhlhauser M, Bruckner I, Berger M, et al. Evaluation of an intensified treatment and teaching programme as routine management of type 1 (insulin dependent) diabetes. The Bucharest–Düsseldorf Study. Diabetologia 1987; 30: 681-690.
- 6. Plank J, Kohler G, Rakovac I, et al. Long-term evaluation of a structured outpatient programme for intensified insulin therapy in patients with Type 1 diabetes: a 12 year follow-up. Diabetologia 2004; 47: 1370-1375.
- 7. Starostina EG, Antsiferov M, Galstyan GR, et al. Effectiveness and cost-benefit analysis of intensive treatment and teaching programmes for type I (insulin dependent) diabetes mellitus in Moscow — blood glucose versus urine glucose self-monitoring. Diabetologia 1994; 37: 170-176.
- 8. Samman A, Muhlhauser I, Bender R, et al. Glycaemic control and severe hypoglycaemia following training in flexible, intensive insulin therapy to enable dietary freedom in people with type 1 diabetes: a prospective implementation study. Diabetologia 2005; 48: 1965-1970.
- 9. Muller UA, Femerling M, Reinauer KM, et al. Intensified treatment and education of type 1 diabetes as clinical routine. A nationwide quality-circle experience in Germany. ASD (the Working Group on Structured Diabetes Therapy of the German Diabetes Association). Diabetes Care 1999; 22 Suppl 2: B29-B34.
- 10. McElduff A, Cheung NW, McIntyre HD, et al. The Australasian Diabetes in Pregnancy Society consensus guidelines for the management of type 1 and type 2 diabetes in relation to pregnancy. Med J Aust 2005; 183: 373-377. <MJA full text>
- 11. Hoogma RP, Hammond PJ, Gomis R, et al. Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial. Diabet Med 2005; 23: 141-147.
- 12. Shearer A, Bagust A, Sanderson D, et al. Cost-effectiveness of flexible intensive insulin management to enable dietary freedom in people with Type 1 diabetes in the UK. Diabet Med 2004; 21: 460-467.
- 13. NHS National Institute for Health and Clinical Excellence. Technology appraisal guidance 60. Full guidance on the use of patient-education models for diabetes. London: NICE, 2003. Available at: http://www.nice.org.uk/page.aspx?o=TA060guidance (accessed Feb 2006).
- 14. Department of Health and Diabetes UK. Structured patient education in diabetes: report from the Patient Education Working Group. London: The Department, 2005. Available at: http://www.dh.gov.uk/PublicationsAndStatistics/Publications/PublicationsPolicyAndGuidance/PublicationsPolicyAndGuidanceArticle/fs/en?CONTENT_ID=4113195&chk=aJYiBB (accessed Feb 2006).
- 15. National Diabetes Support Team (UK). Structured education and support for people with diabetes. Factsheet No. 8. Leicester, UK: The Team, 2005. Available at: http://www.diabetes.nhs.uk/Reading_room/Factsheets.asp (accessed Feb 2006).
- 16. Dose Adjustment for Normal Eating (DAFNE). DAFNE today. Available at: http://www.dafne.uk.com/scripts/professionalhealthcare/dafnetoday.html (accessed Feb 2006).
- 17. Davis TME, Davis WA, Bruce DG. Glycaemic levels triggering intensification of therapy in type 2 diabetes in the community: the Fremantle Diabetes Study. Med J Aust 2006; 184: 325-328. <eMJA full text>
- 18. Larme AC, Pugh JA. Attitudes of primary care providers toward diabetes: barriers to guideline implementation. Diabetes Care 1998; 21: 1391-1396.
I am Director of the Queensland Diabetes Centre, which runs regular DAFNE courses, and President of the DAFNE Association of Australia, a not-for-profit association which promotes and disseminates the DAFNE method and has received funding from Novo Nordisk (Australia) and Abbott Australasia. I have also received speaker fees and assistance in attending meetings from Novo Nordisk and Eli Lilly Australia, manufacturers of insulin products.